Plain-English translation of NCT07122258 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This early-stage safety study is testing a new device called CAROL that uses energy to treat small lung tumors (2 cm or smaller) in patients with non-small cell lung cancer. You would receive one CAROL treatment before having standard surgery to remove the tumor. The study will monitor your safety closely, including how your lungs work and any side effects you experience.
Currently, surgery is the standard treatment for small early-stage lung cancers. This trial is exploring whether using this new treatment device before surgery might improve outcomes or offer additional benefits for patients with very small tumors.
You likely qualify if…
You likely don't qualify if…
You would visit the hospital for screening and pre-procedure tests, then receive the CAROL device treatment followed by surgical removal of your tumor within the same treatment plan. You'll have follow-up visits at 24-36 hours after the procedure, before and after surgery, and then at about 1 and 3 months to check your lungs, breathing, and overall recovery. The study will include imaging scans, breathing tests, blood work, and pain assessments throughout.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Australia